HR 580

structure

Also Known As:

3-methyl-7-(4-(1,4,5,6-tetrahydro-2-pyrimidyl)phenylacetamido)-delta(3)-cephalosporanic acid; HR-580; 3-methyl-8-oxo-7- (((4-(1,4,5,6R-trans-tetrahydro-2- pyrimidinyl)phenyl)acetyl)amino)-5-thia- 1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Amides: 2428
  - Lactams: 2198
    - beta-Lactams: 2386
      - Cephalosporins: 4007
        HR 580: 1
- Sulfur Compounds: 278
  - Thiazines: 3
    - Cephalosporins: 4007
      - HR 580: 1
Heterocyclic Compounds: 198
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - beta-Lactams: 2386
      - Cephalosporins: 4007
        HR 580: 1

Experts

1.	Chen, Fangping: 1 article (03/2009)
2.	Fang, Qiujuan: 1 article (03/2009)
3.	Finkel, Mitchell S: 1 article (03/2009)
4.	Kan, Hong: 1 article (03/2009)
5.	Lewis, William: 1 article (03/2009)
6.	Sharma, Puneet: 1 article (03/2009)

Related Diseases

Ventricular Dysfunction

03/01/2009 - "At 6 months, however, ventricular dysfunction was evident in TG (HR = 580 +/- 47 vs. 673 +/- 25 bpm, TG versus FVB, P < 0.05); LVSP (132 +/- 6 vs. 147 +/- 6 mmHg, TG versus FVB; P < 0.05); LVEDP (15 +/- 4 vs. 8 +/- 6 mmHg, TG vs. FVB, P < 0.05); +dp/dt = 8872 +/- 331 vs. 10026 +/- 796 mmHg/s TG versus FVB, P < 0.01) and -dp/dt (7403 +/- 432 vs. 8835 +/- 368 mmHg/s, TG versus FVB, P < 0.01; n = 8-12, in each group). "